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Abstract In observational studies of survival time featuring a binary time-
dependent treatment, the hazard ratio (an instantaneous measure) is often
used to represent the treatment effect. However, investigators are often more
interested in the difference in survival functions. We propose semiparametric
methods to estimate the causal effect of treatment among the treated with
respect to survival probability. The objective is to compare post-treatment
survival with the survival function that would have been observed in the ab-
sence of treatment. For each patient, we compute a prognostic score (based on
the pre-treatment death hazard) and a propensity score (based on the treat-
ment hazard). Each treated patient is then matched with an alive, uncensored
and not-yet-treated patient with similar prognostic and/or propensity scores.
The experience of each treated and matched patient is weighted using a vari-
ant of Inverse Probability of Censoring Weighting to account for the impact of
censoring. We propose estimators of the treatment-specific survival functions
(and their difference), computed through weighted Nelson-Aalen estimators.
Closed-form variance estimators are proposed which take into consideration
the potential replication of subjects across matched sets. The proposed meth-
ods are evaluated through simulation, then applied to estimate the effect of
kidney transplantation on survival among end-stage renal disease patients us-
ing data from a national organ failure registry.
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1 Introduction
For medical studies in which time to a failure event is of interest, the effect
of a treatment is often estimated by comparing the survival functions for the
treated and untreated groups. When treatment is assigned at baseline (time
t = 0), the estimation of the survival functions is usually straightforward. In
our setting, treatment assignment is time-dependent and a stochastic process
such that subjects typically begin follow-up untreated, with some going on to
receive treatment at some time after baseline. In this report, we are primarily
considering observational studies in which treatment is not assigned at ran-
dom and the rate of treatment assignment may depend strongly on follow-up
time and covariates (Z). Of chief interest is to estimate the average effect of
treatment on the treated (ATT), for the purposes of providing a summary
evaluation of the impact of the treatment under the existing assignment pat-
terns. The ATT is a useful alternative to the average causal effect (ACE), and
may be more relevant and preferred in various settings (including ours) with
respect to policy implications (Heckman et al. 1997; Schafer et al. 2008).
Methods proposed in this report are motivated by the objective of estimat-
ing the effect of deceased-donor kidney transplantation (treatment) compared
to dialysis (“untreated”) on the survival function. End-stage renal disease pa-
tients typically begin therapy on dialysis, with some later receiving a kidney
transplant. The referral of patients for kidney transplantation is not random,
as only patients deemed medically suitable are considered. The goal is to es-
timate the average effect on the survival function of kidney transplantation
under current transplant referral practices; i.e., under the current set of de-
cisions influencing which (and when during follow-up) patients tend to get
transplanted. The ATT, in this context, is intended to contrast the average
post-transplant survival function with the average survival function that would
have been observed (among the transplanted patients) had kidney transplan-
tation not been available.
The effect of a time-dependent treatment is often evaluated using Cox re-
gression, with treatment receipt (yes/no) represented by a time-dependent in-
dicator. From such a model, the treatment effect is usually summarized by the
hazard ratio. However, investigators are often more interested in contrasting
survival (as opposed to hazard) functions, for several reasons. First, the sur-
vival function is more interpretable to non-statisticians than the hazard func-
tion. Second, contrasts between survival functions reflect the cumulative effect
of treatment, rather than instantaneous treatment effect estimated through the
hazard ratio. The hazard ratio estimates the cumulative treatment effect only
under proportionality between the pre- and post-treatment hazard functions,
which one would often prefer not to assume. For example, in the motivating
example described above, non-proportionality of the pre- and post-kidney-
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transplant mortality hazards has been reported in the nephology literature for
more than 10 years (e.g., Wolfe et al. 1999).
Many methods are available in the existing literature for evaluating the
effect of a time-dependent treatment from observational data, as summarized
by Robins and Herna´n (2009). However, most existing methods do not target
the ATT specifically in terms of the survival functions. Marginal structural
models (Robins et al. 2000; Herna´n et al. 2000; Herna´n et al. 2001) and their
history-adjusted versions (e.g., Petersen et al. 2007) typically estimate the
causal hazard ratio (HR) as a measure of the ACE of treatment. When fitted
though g-estimation (Robins et al. 1992; Lok et al. 2004; Herna´n et al. 2005),
structural nested failure time models (SNFTMs) often use the accelerated
failure time model as the basis for the time-dependent treatment effect, in
which case mean survival times are contrasted, but not survival functions.
When fitted through parametric g-computation (Robins, 1986, 1987 and 1988;
Taubman et al. 2009), SNFTMs could in principle be used to estimate the
survival function-based ATT of interest in the current report. Disadvantages
of such an approach include the need to bootstrap and greater sensitivity
towards any model misspecification (Taubman et al. 2009). Further comparison
between the proposed methods and existing approaches is deferred to Section
5.
When treatment is time-dependent, it is generally not straightforward to
compare the average post-treatment and treatment-free survival functions.
Several authors have advocated landmark methods (e.g., Feuer et al. 1992).
However, the selection of the landmark times at which to classify patient
treatment status is arbitrary. The methods of Feuer et al (1992) were not
designed to incorporate covariates. More recent related work includes that
of Van Houwelingen (2007) and Van Houwelingen and Putter (2007), which
accommodated covariates but did not consider the average treatment effect.
In this paper, we propose matching methods to estimate ATT. Compared
with alternative methods, the matching methods have the advantages of han-
dling covariates of higher dimensions, greater robustness towards model mis-
specifications and less stringency towards positivity assumptions (Rosenbaum
and Rubin, 1983). Furthermore, matching can be more intuitive to researchers
and does not rely on structural models. We propose to select matches to serve
as potential treatment-free counterfactuals (or controls) for treated patients.
Specifically, for a patient initiating treatment at a certain follow-up time (e.g.,
time T ), we propose to select his match from patients alive, uncensored and
not-yet-treated at time T . The matched patient is intended to be very similar
to the treated patient, such that their follow-up (after time T ) reflects what
would have been the treated patient’s experience, had (contrary to fact) that
patient not been treated. We consider 1:1 matching, which equalizes the follow-
up time distribution (i.e., previous time survived) prior to time T between the
treated and matched yet-untreated subject. We consider two scores by which
to match patients: (1) a propensity score which measures the patient-specific
rate of treatment assignment, given the covariates (2) a prognostic score which
represents the pre-treatment death hazard. Hence, such matching balances the
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covariate distribution by requiring the matched patient to be very similar to
the treated patient with respect to the rate of receiving treatment and/or
the rate of dying in the absence of treatment. After appropriate reweighting,
group-specific survival curves are then estimated and compared nonparamet-
rically such that no functional form for the treatment effect is assumed. We
target at ATT and the time-dependent treatment of interest is non-reversible.
It is an important special case of time-varying treatment regimes and the
estimation process through matching raises non-trivial technical challenges.
Several complications arise from censoring that have the potential to bias a
survival function estimator. First, the treatment time (T ) is subject to censor-
ing, such that longer times-to-treatment are more likely to be censored. Hence,
the observed distribution of T is generally a biased sample of shorter T values.
Second, the treatment time T and the post-treatment death time (D−T ) are
not usually independent. Thus, (D − T ) is inherently subject to dependent
censoring, a phenomenon referred to in the gap time literature as induced
dependent censoring (e.g., Lin, Sun and Ying 1999; Schaubel and Cai 2004).
Third, matched yet-untreated patients can later receive treatment after being
matched. To eliminate these sources of biases, we weight the estimators using
a variant of Inverse Probability of Censoring Weighting (IPCW; Robins and
Rotnitzky 1992; Robins and Finkelstein 2000) in order to recover the survival
and time-to-treatment distributions that would be observed in the absence of
censoring.
The remainder of this article is organized as follows. In Section 2, we will de-
scribe our proposed methods, including the pertinent counterfactuals, match-
ing design and assumed models, proposed treatment effect and variance esti-
mators. In Section 3, we conduct simulations to evaluate the performance of
the survival estimators and the associated variance estimators. Furthermore,
we evaluate the bias and efficiency of the survival estimators when one or
both scores are used to conduct matching. In Section 4, we apply the methods
to national end-stage renal disease data. We conclude the paper with some
discussion in Section 5.
2 Methods
In this section, we define the quantity of interest, then describe the criteria and
process to select matches for each treated patient. We then address the issue of
censoring and the need to weight the analysis. Next, we introduce our proposed
estimators of the post-treatment and treatment-free survival functions, and the
difference therein; after which, variance estimation is outlined.
2.1 Notation, Quantity of Interest and Identifiability
We begin by setting up the requisite notation. Let Di denote the death time
and Ci the censoring time for subject i (i = 1, . . . , n). The observation time
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is denoted by Ui = Di ∧ Ci, with a ∧ b = min{a, b}, and the death indicator
is given by ∆i = I(Di < Ci) where I(A) is an indicator function taking the
value 1 when event A is true and 0 otherwise. The at-risk indicator is defined
as Yi(t) = I(Ui ≥ t). Let Zi be the covariate vector, which is assumed to not
depend on time. The treatment time is represented by Ti, with corresponding
indicator ∆Ti = I(Ti < Ui). We assume that, conditional on Zi, Di and Ti
are independently censored by Ci. A few comments are in order regarding
our data structure. As implied previously, patients begin follow-up (t = 0)
untreated, with some subsequently receiving treatment and others dying first.
Treatment does not censor death, but does naturally preclude treatment-free
death. Correspondingly, death prevents future treatment initiation, as in the
competing risks setting.
As stated in the preceding paragraph, we assume that the covariate, Zi,
does not vary with time. Several of the methods cited in Section 1 are able
to accommodate time-varying covariates. Three ideas are important in this
regard. First, with respect to the proposed methods, the innovation relates
to the methods of estimation and (to some extent) the estimands themselves,
as opposed to the underlying data structure. Second, data sets with time-
constant covariates are common in practice; such as administrative databases,
including that which motivates our current work. Third, it appears that the
proposed methods could be extended to the time-dependent covariate setting
with little modification. These are issues we return to in Section 5.
We define the parameter of interest in the causal inference framework.
Typically, this framework hypothesizes the setting wherein each individual
has two potential outcomes (Rubin 1974 and 1978), corresponding to the two
possible treatment regimes (e.g., treated and untreated). We modify this struc-
ture to accommodate our setting. Let D1i (Ti) denote the potential death time
(measured from time 0) if patient i is treated at Ti. The counterfactual quan-
tity D0i (Ti) denotes the potential death time if, contrary to fact, patient i
never received treatment. Note that, by definition, both D0i (Ti) and D
1
i (Ti)
are greater than Ti and the counterfactuals are only defined in individuals that
begin treatment. In the absence of censoring, D1i (Ti) = Di. We assume that
D1i (Ti) and D
0
i (Ti) are conditionally independent of the treatment assignment
given the observed covariates, known as the strong ignorability assumption
(Rubin, 1974). We also assume the stable unit treatment value assumption
(Rubin 1980).
Our objective is to estimate the average effect of the treatment among the
treated, a frequently employed measure in the causal inference literature. The
treatment decision depends on Zi and untreated patients may never be eligible
for treatment. Additionally, the benefit of treatment is only realized among
patients who actually receive treatment. Hence, the ATT can be more desirable
in practice than the average causal effect (ACE). For patient i, let D˜1i (Ti)
denote the potential remaining survival time following treatment assignment
at Ti, such that D˜
1
i (Ti) = D
1
i (Ti) − Ti. Conversely, let D˜0i (Ti) denote the
potential remaining survival time if the patient never receives treatment; i.e.,
D˜0i (Ti) = D
0
i (Ti) − Ti. In the absence of censoring, the survival functions
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corresponding to these newly defined variates are given by,
Sij(t) = P{D˜ji (Ti) > t|Ti,Zi, Ti < Di}, j = 0, 1
and the subject-specific treatment effect can be defined as
δi(t) = Si1(t)− Si0(t).
Having described the treatment effect at the individual level, we now denote
the average causal treatment effect among the treated as
δ(t) = S1(t)− S0(t), (1)
where S0(t) and S1(t) are average survival functions,
Sj(t) = E{Sij(t)} (2)
with the expectation being with respect to the distribution of {T,Z|T < D};
i.e., the joint distribution of (T,Z) among patients with T < D, which ac-
counts for the competing risks relationship between T and D. In addition to
our inherent interest in the ATT, it should be noted that what makes the
estimation of the ATT more feasible than the ACE in our setting is that we
only observe the pre-treatment duration (T ) for subjects observed to receive
treatment.
It is important to understand which quantities pertinent to estimating
the ATT can be identified by observed data. In the absence of censoring,
we would observe D˜1(T ) for each treated patient and, hence, could estimate
P{D˜1(T ) > t|Z, T, T < D} which is equal to P{(D − T ) > t|Z, T, T < D}
under the strong ignorability assumption. However, we do not observe data to
estimate P{D˜0(T ) > t|Z, T, T < D} since a subject’s treatment-free experi-
ence is censored at the time of treatment. Therefore, we use matching methods
to choose proper substitutions from the alive, uncensored and not-yet-treated
patients. Specifically, we achieve this by hard-matching on T and matching
on Z using a prognostic score and/or propensity score, p(Z), to select closest
matches to serve as treatment-free counterfactuals for each treated patient.
To estimate the ATT, instead of averaging over the conditional distribution,
(T,Z|T < D), we average over the distribution of {T, p(Z)|T < D} and
apply the result that the potential remaining survival times after T are con-
ditionally independent of the treatment assignment given the matching scores
(Rosenbaum and Rubin 1983; Lu 2005). We also assume that subjects with the
same Z have a positive probability of being in both treatment groups (Heck-
man, LaLonde and Smith 1999) or an overlapping support for treated and
untreated patients. Additionally, we assume no unmeasured confounders or
measurement errors or model misspecifications. See related discussions on as-
sumptions required for matching (Bryson, Dorsett and Purdone 2002; Caliendo
and Kopeinig 2005; Rosenbaum and Rubin 1983; Stuart 2010). In the pres-
ence of censoring, instead of estimating P{D˜j(T ) > t|Z, T, T < D}, we can
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estimate P{D˜j(T ) > t|Z, T,∆T = 1}, assuming that censoring is condition-
ally independent given Z. The implications of censoring will be addressed in
details in Subsections 2.3 and 2.4.
In the next subsection, we describe how to select matches for treated pa-
tients in order to estimate P{D˜0(T ) > t|Z, T,∆T = 1}.
2.2 Matching schemes
We consider two scores as potential matching criteria. The first is a propensity
score, based on the cause-specific hazard of initiating treatment at time t given
alive and untreated,
λiT (t) = lim
dt→0
1
dt
P (t ≤ Ti ∧Di < t+ dt, Ti < Di|Ti ∧Di ≥ t,Zi),
for which we assume the following Cox model,
λiT (t) = λ0T (t) exp(β
′
TZi), (3)
where λ0T (t) is an unspecified baseline hazard and βT is a vector of unknown
parameters. Cox regression is used due to its familiarity and flexibility. For each
treated patient, we select matches among at-risk and not-yet-treated patients.
For example, consider finding matches for patient k, who is treated at time
Tk. Potential controls for patient k are patients who are alive, uncensored and
untreated as of time t = Tk, including subjects who are later treated at time
t > Tk. We compare treated patient, k, and a potential control, `, with respect
to treatment propensity through the ratio
ψT`:k ≡
λlT (Tk)
λkT (Tk)
=
λ0T (Tk) exp(β
′
TZ`)
λ0T (Tk) exp(β
′
TZk)
= exp{β′T (Z` −Zk)}. (4)
The fact that the baseline hazard cancels out simplifies computation consider-
ably. Patient ` is a suitable match to treated patient k to the extent that ψT`:k is
close to 1. To avoid inappropriate matches, we add the restriction that the ψT`:k
needs to be within a caliper, ψT`:k ∈ (ξ−1T , ξT ) for small ξT . The finite sample
positivity assumption and the overlapping common support will impact the
selection of ξT . We select as a match for treated patient k the patient ` with
the minimum | logψT`:k| among at-risk and untreated patients. It is possible
that a treated patient cannot be matched to any control, and such patients
are excluded from further analysis.
A second score to be used to choose matches instead of (or, in addition to)
ψT`:k is a prognostic score, reflecting the treatment-free death hazard,
λiD(t) = lim
δ→0
1
δ
P (t ≤ Di < t+ δ|Di ≥ t, Ti > t,Zi),
which we model by
λiD(t) = λ0D(t) exp(β
′
DZi). (5)
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To fit this model using standard partial likelihood (Cox 1975) methods, we
assume that both Ti and Ci independently censor D
0
i (Ti) given Zi. Analogous
to our use of ψT`:k described above, we define
ψD`:k = exp{β′D(Z` − Zk)}, (6)
then select the match to treated patient k the at-risk and yet-untreated patient
` for which | logψD`:k| is minimized, provided that ψD`:k ∈ (ξ−1D , ξD) for small
ξD. We also consider the simultaneous use of both propensity and prognostic
scores, in which case the matching requirement would be that ψT`:k ∈ [ξ−1T , ξT ],
ψD`:k ∈ [ξ−1D , ξD], and that | log{ψT`:kψD`:k}| is the minimum among at-risk pa-
tients yet-untreated as of time t = Tk.
The matching algorithm we propose entails matching-with-replacement in
the sense that a patient, while untreated, can be matched to multiple treated
patients. Hence, each treated patient is matched to its nearest neighbor within
a caliper, even if that subject has been matched to other treated patients at
previous times. Figure 1 serves as an illustration of the matching scheme with
n = 4 hypothetical patients. Following the cohort from time t = 0 forward,
patient i = 2 receives treatment at time t = T2, and patients i = 1, 3, 4 are all
potential matches. The next observed treatment time is t = T1, with patient
i = 3 being the only potential match. Hence, patient i = 1 is both a potential
control for patient i = 2 at t = T2 and subsequently a treated patient at
t = T1. Patient i = 3 is a potential match for i = 2 at t = T2 and then again
for i = 1 at t = T1. Note that, if patient i = 1 was selected as a match at
t = T2, then D1 does not count as a treatment-free death in this matched
set, since i = 1 is censored upon treatment initiation at time t = T1 in this
matched set.
Having described how to select matches for the treated patients, we next
describe how to estimate S1(t) and S0(t) defined by (2), as well as the quantity
of chief interest, δ(t) defined by (1).
2.3 Estimation of S1(t)
Having created treated and untreated samples that are matched with respect
to previous time survived and Z, it is appealing to estimate S1(t) and S0(t)
nonparametrically. Recall that the at-risk indicator is defined as Yi(t) = I(Ui ≥
t). The observed death counting process is set to Ni(t) = ∆iI(Ui ≤ t), with
associated increment dNi(t) = Ni(t
− + dt) − Ni(t−). In addition, we define
the treatment counting process as NTi (t) = ∆
T
i I(Ti ≤ t). We also define
Y 1i (t) = I(Ui ≥ t, Ti < t), which equals 1 when subject i is at risk at time
t and has already initiated treatment. Correspondingly, we define the post-
treatment counting process increment, dN1i (t) = Y
1
i (t)dNi(t). Recall that we
are analyzing time since treatment initiation, essentially re-setting the time
clock for treated patient, k, to 0 at the time of treatment, Tk. It is then
convenient to establish notation that captures the transformed time scale,
including Y˜ 1k (t) = Yk(Tk + t) and dN˜
1
k (t) = dN
1
k (Tk + t).
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i=1 
i=2 
i=3 
i=4 
t  (follow up time) 
T1 
D3  
T2 
C4 
D1  
C2 
Fig. 1 Matching Scheme Illustration
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One might hope that this could be accomplished through, for example, the
Nelson-Aalen estimator of the cumulative hazard function,
n∑
k=1
∫ t
0
{
n∑
`=1
Y˜ 1` (u)
}−1
dN˜1k (u). (7)
However, as we describe below, this turns out not to be the case for several rea-
sons. First, (7) represents an unweighted average over the observed treatment
times. Since Tk is subject to right censoring by Ck, the uncensored Tk values
represent a biased sample of shorter values of times-to-treatment. Just as one
would not use the empirical cumulative distribution function for estimation
in the standard univariate survival set-up, a method that explicitly accounts
for censoring is required here so that the resulting nonparametric estimator of
S1(t) represents an average over the {T,Z|T < D} distribution, as opposed
to a distribution that depends on C.
Second, the length of T affects the probability that (D − T ) is observed
as opposed to being censored. That is, since we assume one single censoring
time, (D − T ) is censored by (C − T ) which induces dependent censoring
(Schaubel and Cai 2004) unless (D−T ) is independent of T , usually an unre-
alistic assumption in practice. Viewing (D− T ) as a gap time brings forth an
identifiability issue (Lin, Sun and Ying 1999). Specifically, if we let τC be the
maximum censoring time, then inference is restricted to T ∈ [0, τ ] with S1(t)
estimable on t ∈ [0, τ1] for τ + τ1 ≤ τC .
Third, even leaving aside the first and second issues described above, C
still causes difficulty. For instance, suppose that no T values were censored;
that (D−T ) is independent of T ; but that post-treatment death time, (D−T )
is still subject to right censoring. The variates (D− T ) and (C − T ) are likely
to be correlated through their mutual association with Z, akin to the type of
dependent censoring described by Robins and Rotnitzky (1992).
Both the first and third issues described in the preceding paragraphs imply
re-weighting the post-treatment data to reflect that which would be observed
in the absence of censoring. The second issue implies redefining the post-
treatment survival function as S1(t|T ≤ τ) for t ∈ [0, τ1]. Combining these
considerations, the post-treatment weight function for subject k is then given
by
w1k(t) =
NTk (τ)I•:kY˜
1
k (t)
P (Ck > Tk + t|Zk, Tk) , (8)
where NTk (τ) reflects the above-described identifiability constraints, I•:k is
an indicator for treated patient k being successfully matched and P (Ck >
Tk + t|Zk, Tk) is the IPCW component applied so that the observed data
reflect what would have been observed in the absence of censoring. It is useful
to write,
P (Ck > Tk + t|Zk, Tk) = P (Ck > Tk|Zk, Tk) P (Ck > Tk + t|Ck > Tk,Zk, Tk),
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where the first term on the right side represents the probability that treat-
ment time for subject k is uncensored; while the second term represents the
probability the post-treatment death time is uncensored as of t units follow-
ing the uncensored treatment time. All instances of the risk set indicator in
the unweighted estimator (7) including that in dN˜1k (u) will be replaced with
w1k(t), noting that the counting process increment in (7) is by definition equal
to Y˜k(t)dN˜
1
k (u).
It is evident now that we require a model for Ci, and we assume that
λiC(t) = lim
dt→0
1
dt
P (t ≤ Ci < t+ dt|Ci ≥ t,Zi),
follows the Cox model,
λiC(t) = λ0C(t) exp(β
′
CZi). (9)
Recall that Ci is assumed to be conditionally independent of Ti and Di given
Zi, meaning that Λ0C(t) =
∫ t
0
λ0C(u)du and βC can be consistently estimated
through standard (unweighted) Cox regression.
Finally, our proposed estimator of S1(t) is given by Ŝ1(t) = exp{−Λ̂1(t)},
where
Λ̂1(t) =
n∑
k=1
∫ t
0
{
n∑
`=1
ŵ1` (u)
}−1
ŵ1` (u)dN˜
1
k (u) (10)
and we set
ŵ1k(t) = N
T
k (τ)I•:kY˜
1
k (t) exp
{
Λ̂kC(Tk + t)
}
, (11)
where Λ̂kC(Tk + t) =
∫ Tk+t
0
λ̂kC(u)du.
Considerations on the treatment-free side are somewhat different from
those outlined in this subsection, as we now describe.
2.4 Estimation of S0(t) and δ(t)
We begin by defining additional notation pertinent to treatment-free data.
Specifically, let Y 0i (t) = I(Ui ∧ Ti ≥ t), an indicator for being at risk and
untreated as of time t, and define the following counting process increment,
dN0i (t) = Y
0
i (t)dNi(t). Suppose that patient k is observed to initiate treatment
at time Tk. We then let Ii:k be an indicator for not-yet-treated subject i being
matched to patient k, with Ik:k ≡ 0. Since we apply one-to-one matching,
we have I•:k =
∑n
i=1 Ii:k, consistent with the definition of I•:k applied in (8).
To specify matched-set-specific notation, we define Y˜ 0i:k(t) = Y
0
i (Tk + t) and
dN˜0i:k(t) = dN
0
i (Tk + t).
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As was the case for S1(t), we estimate S0(t) through a weighted version of
the Nelson-Aalen estimator, with the weight function for patient i given by
w0i:k(t) =
NTk (τ)Ii:kY˜
0
i:k(t)
P (Ck > Tk|Zk, Tk)P (Ci ∧ Ti > Tk + t|Ci ∧ Ti > Tk, Tk,Zi) .(12)
The component NTk (τ)P (Ck > Tk|Zk, Tk)−1 is appropriately inherited from
the weight assigned to the treated patient. A treated patient does not con-
tribute to Ŝ1(t) unless Tk < τ . Correspondingly, patient i, matched to treated
patient k, should not contribute to Ŝ0(t) unless patient k was included. With
respect to the denominator, intuitively, inverse weighting patients i and k dif-
ferently at the time of matching (t = Tk) would serve to distort the balance
in the covariates and previous-time-survived distributions achieved by match-
ing. The gap time structure does not induce dependent censoring observed
witnessed on the post-treatment side. The pertinent gap times are Tk and
(D0i − Tk). The latter is censored by (Ci − Tk) but, unlike the analog on the
j = 1 side, (D0i − Tk) can in fact be assumed to be independent of Tk. There-
fore, the induced dependent censoring and associated identifiability issues do
not naturally arise on the treatment-free side. That said, we apply the afore-
listed constraints to S0 since it is desirable to contrast S1 and S0 functions
which are truly comparable.
The third issue described in Subsection 2.3 is arguably a greater concern
on the treatment-free side since, for matched patient i, (D0i − Tk) can be cen-
sored by either (Ci−Tk) or (Ti−Tk); both represent violations of independent
censoring due to shared dependence on Zi, in the context of nonparametric
survival curve estimation. Note that our goal is to inversely weight the uncen-
sored treatment-free experience with respect to the distribution at t = Tk as
opposed to t = 0; hence, the conditional probabilities.
The estimated version of (12) can be expressed as
ŵ0i:k(t) = N
T
k (τ)Ii:kY˜
0
i:k(t) exp
{
Λ̂kC(Tk) +
∫ Tk+t
Tk
dΛ̂iC(u) +
∫ Tk+t
Tk
dΛ̂iT (u)
}
,
(13)
where Λ̂iT (t) =
∫ t
0
λ̂iT (u)du.
Our proposed estimator of S0(t) is given by Ŝ0(t) = exp{−Λ̂0(t)}, where
Λ̂0(t) =
n∑
i=1
n∑
k=1
∫ t
0
{
n∑
`=1
n∑
k=1
ŵ0`:k(u)
}−1
ŵ0i:k(u)dN˜
0
i:k(u). (14)
Note that in the treated group (j = 1), every patient is unique but in the
untreated group (j = 0), the same patient can appear in multiple matched
sets.
Having estimated S1(t) and S0(t), the ATT is then estimated by δ̂(t) =
Ŝ1(t)− Ŝ0(t).
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2.5 Variance Function
The bootstrap (Efron 1979) is a frequently used method to estimate variances
in settings such as ours where methods of analytically deriving the variance are
difficult. However, Abadie and Imbens (2008) have shown that standard boot-
strap is usually not valid for matching estimators. We propose a closed-form
estimator that is convenient to compute. The aim is to arrive at a tractable
form which captures the most important aspects of the variability in the pro-
posed estimators. We begin by considering the post-treatment side (j = 1).
Assuming that {Yi(·), Ni(·), NTi (·),Zi} are independent and identically dis-
tributed for i = 1 . . . , n, ignoring the randomness in the matching process and
treating the weights as known, n1/2{Λ̂1(t)−Λ1(t)} = n1/2
∑n
i=1 φ
1
i (t) asymp-
totically, where φ1i (t) =
∫ t
0
pi1(u)
−1w1i (u)dM˜
1
i (u), with pi1(u) = E[w
1
i (u)] and
dM˜1i (u) = dN˜
1
i (u) − Y˜ 1i (u)dΛ1(u) (e.g., see Andersen et al. 1993). Under
mild regularity conditions, the {φ11(t), . . . , φ1n(t)} are independent and identi-
cally distributed mean 0 variates. As a result, n1/2{Λ̂1(t) − Λ1(t)} converges
to asymptotically to a mean-zero Normal distribution with variance E[φ1i (t)
2],
by the Multivariate Central Limit Theorem. By applying the Functional Delta
Method (van der Vaart 2000), we obtain that n1/2{Ŝ1(t)−S1(t)} is also asymp-
totically mean-zero Normal with variance estimator,
σ̂21(t) = n
−1
n∑
i=1
{Ŝ1(t)φ̂1i (t)}2,
where φ̂1i (t) =
∫ t
0
pi1(u)
−1ŵ1i (u)dM̂
1
i (u), with pi1(u) = n
−1∑n
i=1 ŵ
1
i (u) and
dM̂1i (u) = dN˜
1
i (u) − Y˜ 1i (u)dΛ̂1(u). This is a robust version of the variance
estimator and, as such, does not rely on Martingale theory (Fleming and Har-
rington 1991).
Then considering the treatment-free side (j = 0), analogous arguments lead
to n1/2{Ŝ0(t)−S0(t)} = −n1/2
∑n
i=1 S0(t)φ
0
i (t) asymptotically. Different from
the treatment side where each subject k can appear only once, a given subject i
in the treatment-free side can be matched to several treated patients. As such,
the asymptotically independent terms with respect to the treatment-free side
are given by φ0i (t) =
∑n
k=1
∫ t
0
pi0(u)
−1w0i:k(u)dM˜
0
i:k(u), and n
1/2{Ŝ0(t)−S0(t)}
converges in distribution to a zero-mean Normal with a variance that can be
consistently estimated by
σ̂20(t) = n
−1
n∑
i=1
{Ŝ0(t)φ̂0i (t)}2,
where we define
φ̂0i (t) =
n∑
k=1
∫ t
0
pi0(u)
−1ŵ0i:k(u)dM̂
0
i:k(u)
pi0(u) = n
−1
n∑
i=1
n∑
k=1
ŵ0i:k(u),
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with dM̂0i:k(u) = dN˜
0
i:k(u)− Y˜ 0i:k(u)dΛ̂0(u).
Combining the above results, we can represent n1/2{δ̂(t)− δ(t)} asymptot-
ically by n−1/2
∑n
i=1{S0(t)φ0i (t) − S1(t)φ1i (t)}, where S0(t)φ0i (t) − S1(t)φ1i (t)
components are independent and identically distributed with mean 0 and ac-
count for the possibility that patients may contribute follow-up on both the
j = 0 and j = 1 sides. The quantity n1/2{δ̂(t) − δ(t)} converges asymptoti-
cally to a Normal variate with mean 0 and a variance that can be consistently
estimated by
σ̂2δ (t) = n
−1
n∑
i=1
{Ŝ0(t)φ̂0i (t)− Ŝ1(t)φ̂1i (t)}2.
The above-described variance estimators ignore the randomness in the
matching process and the estimation of the weights. The idea of treating the
weights as fixed for computational purposes is a commonly used simplification
in the inverse weighting literature. In several analogous cases in the literature,
it is argued that treating an estimated weight as known reduces precision
(Herna´n, Brumback and Robins 2000 and 2001); heuristically, since the esti-
mation is not credited for the extent to which it uses the data. On the other
hand, not accounting for matching process should result in under-estimation
of asymptotic variances. However, our extensive simulations show that the
randomness we ignored is usually small or almost negligible relative to the
variability that is captured by φ̂1i (t) and φ̂
0
i (t) in even moderate sized samples.
3 Simulations
We conducted simulations to assess the performance of our proposed method
in finite samples. The treatment times T were generated from an exponential
distribution with hazard λ0T exp{β10Z1 + β11Zt}, while treatment-free death
times were generated as exponential with hazard λ0D exp{β20Z1 + β21Zd}.
Note that the covariate Zt affects treatment assignment, but not death, while
Zd has the opposite effect. The covariate Z1 serves as a confounder that af-
fects the rates of both treatment and treatment-free death. Times between
treatment and death are generated from an exponential distribution with rate
λ1D exp{β30Z1 + β31Zd + β32}. Censoring times are generated from an ex-
ponential distribution with rate λ0C exp{β40Z1}. Each of the covariates Z1,
Zt and Zd were generated from standard normal distributions. There were
n=1,000 subjects in all simulations, with each data configuration replicated
1,000 times. In reality, we observe the minimum of the potential time to treat-
ment, time to death and time to censoring. In simulations, however, we have
every patient’s potential time to treatment, time to death with and without
treatment and time to censoring. As such, we can obtain the true effect of the
treatment on survival by averaging the difference between the counterfactual
survival functions across simulations.
In the first set of simulations, we examine the bias and empirical standard
deviation of the proposed estimators using three different matching methods:
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(i) matching by prognostic score only (ii) matching by propensity score only
(iii) matching by both prognostic and propensity scores; i.e., double match-
ing. We do 1:1 nearest-neighbor within-caliper matching, with ξT = 1.1 and/or
ξD = 1.1. Approximately 75% treated patients find their matches in simula-
tions. We first vary the magnitude of β11 from 0, 0.5, 1 to 1.5 to change
the degree of association between the predictor Zt and the treatment haz-
ard from none, weak, moderate and strong, respectively. We then vary the
magnitude of β21 from 0, 0.5, 1 to 1.5 to change the degree of association
between the predictor Zd and the treatment-free death hazard. The remaining
parameter specifications were equal across all simulations: λ0T = 0.5, λ0D =
0.5, λ1D = 0.2, λ0C = 0.2, β10 = 0.15, β20 = 0.25, β30 = 0.20, β31 = 0.15, β32 =
−0.7, β40 = 0.2. We set τ = 3 and τ1 = 5. We present the average bias and
the empirical standard deviation (ESD) of Ŝ1(t), Ŝ0(t) and δ̂(t) at t = 1.5.
In the second set of simulations, we examine the properties of the proposed
point estimators and their variance functions under four scenarios: (1) no treat-
ment effect, where λ0T = 0.7 and λ0D = 0.7 = λ1D = 0.7, β20 = 0.25, β21 =
0.50, β30 = 0.20, β31 = 0.50, β32 = 0; (2) strong treatment effect, where λ0T =
0.5, λ0D = 0.5, λ1D = 0.5, β20 = 0.5, β21 = 1, β30 = 0.20, β31 = 0.15, β32 = −1;
(3) moderate treatment effect, where λ0T = 0.5, λ0D = 0.5, λ1D = 0.7, β20 =
0.25, β21 = 0.5, β30 = 0.20, β31 = 0.15, β32 = −0.7; (4) negative treatment
effect, where λ0T = 0.5, λ0D = 0.5, λ1D = 0.7, β20 = 0.25, β21 = 0.5, β30 =
0.20, β31 = 0.15, β32 = 0.4. The other parameter specifications were the same
across all scenarios: β10 = 0.15, β11 = 0.5, λ0C = 0.2 and β40 = 0.2. We
conducted nearest-neighbor within-caliper prognostic score matching, with
ξD = 1.1. We examined the proposed estimators (and their estimated standard
errors) at t = 0.5, t = 1 and t = 1.5.
As shown in Table 1, the bias appears to be negligible for each of the pro-
posed estimators. For Ŝ0(t), double matching method tends to give estimates
with the smallest bias, followed by prognostic matching. For Ŝ0(t) and δ̂(t),
prognostic score matching method tends to give much smaller empirical stan-
dard deviations, which are only 50% to 80% of those by either propensity score
matching or double matching, except when β11 = 0. Propensity score match-
ing and double matching give rise to similar ESDs. Such results are consistent
with the need to adjust for prognostic factors for the benefit of efficiency gain.
As we increase the association between Zt and T through β11, both propen-
sity score and double score matching methods tend to give increased empirical
standard deviations. This illustrates that adjustment for a factor that is a
stronger predictor of the treatment can actually lead to a increased variance if
the factor is not a predictor of the outcome. For Ŝ1(t), differences in bias and
empirical standard deviation between prognostic and propensity score match-
ing methods are negligible in our simulations since almost all treated patients
are able to find matches.
The performances of the estimators of the survival functions and their
variances in our simulations are summarized in Tables 2 and 3. We find that
the biases are again negligible for all estimates of S0, S1 and δ at 0.5, 1
and 1.5 years post treatment. The asymptotic standard errors are close to
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Table 1 Bias and empirical standard deviation (ESD) of the estimates for survival functions
for the untreated (Sˆ0) and treated (Sˆ1) patients, and their difference in survival (δˆ) at 1.5
years post treatment summarized across 1000 simulations where the association between
Zt and T (β11) and that between Zd and D
0 (β21) vary and three matching methods are
considered
β11 β21 Matching Sˆ0 Bias ESD Sˆ1 Bias ESD δˆ Bias ESD
0 1 Prognostic 0.545 0.006 0.041 0.865 0.001 0.019 0.320 -0.006 0.045
0.5 1 0.540 0.007 0.041 0.865 -0.000 0.019 0.325 -0.008 0.044
1 1 0.531 0.006 0.042 0.864 0.000 0.019 0.333 -0.006 0.046
1.5 1 0.521 0.006 0.044 0.863 0.001 0.020 0.342 -0.005 0.049
0 1 Propensity 0.545 0.006 0.042 0.865 0.001 0.019 0.320 -0.005 0.046
0.5 1 0.540 0.008 0.049 0.865 0.000 0.019 0.325 -0.008 0.052
1 1 0.531 0.008 0.070 0.864 0.000 0.019 0.333 -0.008 0.072
1.5 1 0.521 0.013 0.089 0.863 0.001 0.020 0.342 -0.012 0.092
0 1 Double 0.545 0.003 0.042 0.865 0.001 0.020 0.320 -0.003 0.046
0.5 1 0.540 -0.002 0.049 0.865 -0.000 0.023 0.325 0.002 0.054
1 1 0.531 -0.002 0.065 0.864 0.000 0.024 0.333 0.002 0.069
1.5 1 0.521 0.004 0.087 0.863 0.000 0.026 0.342 -0.003 0.091
1 0 Prognostic 0.472 0.000 0.046 0.859 -0.001 0.019 0.387 -0.001 0.049
1 0.5 0.488 0.003 0.043 0.861 0.000 0.019 0.373 -0.003 0.046
1 1 0.531 0.006 0.042 0.864 0.000 0.019 0.333 -0.006 0.046
1 1.5 0.580 0.011 0.043 0.866 0.001 0.019 0.286 -0.010 0.047
1 0 Propensity 0.472 0.005 0.070 0.859 -0.001 0.019 0.387 -0.006 0.072
1 0.5 0.488 0.007 0.072 0.861 0.000 0.019 0.373 -0.006 0.075
1 1 0.531 0.008 0.070 0.864 0.000 0.019 0.333 -0.008 0.072
1 1.5 0.580 0.012 0.069 0.866 0.001 0.019 0.286 -0.011 0.072
1 0 Double 0.472 0.004 0.067 0.859 -0.000 0.020 0.387 -0.004 0.070
1 0.5 0.488 0.003 0.064 0.861 0.001 0.021 0.373 -0.003 0.067
1 1 0.531 -0.002 0.065 0.864 0.000 0.024 0.333 0.002 0.069
1 1.5 0.580 -0.006 0.067 0.866 -0.000 0.027 0.286 0.006 0.071
the empirical standard deviation of the estimates across all simulations, even
when the estimates are relatively small (e.g., δ, Table 2). Both the biases and
variances of the estimates tend to be larger at t = 1.5 than those at t = 0.5
because fewer subjects remain at-risk. Coverage probabilities are generally
close to the nominal level of 0.95.
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Table 2 Simulation summary of estimates of survival functions for the treated (S1) and
untreated (S0) patients, and their difference (δ) at time t post treatment; Est: average of
estimates of quantity of interest across 1000 simulations; Bias: average bias across simula-
tions; ESD: empirical standard deviation of estimates from 1000 simulations; ASE: average
of estimated standard errors across simulations; CP: coverage probability of nominal 95%
confidence interval; Null: no treatment effect; Strong: strong treatment effect.
Setting t Quantity Est Bias ESD ASE CP
Null 0.5 S0(t) 0.710 0.001 0.027 0.028 94.9
1.0 0.519 0.001 0.038 0.038 95.0
1.5 0.391 0.003 0.044 0.045 95.3
0.5 S1(t) 0.711 0.003 0.022 0.023 94.6
1.0 0.520 0.003 0.026 0.026 93.7
1.5 0.389 0.003 0.027 0.026 93.7
0.5 δ(t) 0.001 -0.000 0.035 0.036 95.7
1.0 0.001 0.002 0.046 0.046 94.3
1.5 -0.002 -0.001 0.051 0.052 94.6
Strong 0.5 S0(t) 0.790 0.008 0.023 0.025 94.9
1.0 0.652 0.008 0.033 0.034 93.8
1.5 0.554 0.008 0.040 0.041 94.1
0.5 S1(t) 0.916 0.001 0.015 0.015 93.8
1.0 0.840 0.001 0.020 0.020 95.0
1.5 0.769 0.001 0.024 0.023 94.3
0.5 δ(t) 0.126 -0.007 0.027 0.029 95.3
1.0 0.187 -0.007 0.039 0.040 94.8
1.5 0.215 -0.007 0.046 0.048 94.9
4 Application
We applied the proposed methods in order to estimate the effect of deceased-
donor kidney transplantation (j = 1) on survival compared to dialysis (j = 0)
among end-stage renal disease patients. Data were obtained from the Cana-
dian Organ Replacement Register, a nation-wide and population-based organ
failure registry. The study population included n=27,424 patients aged ≥18
years who initiated dialysis in Canada between 1989 and 1998. Patients began
follow-up at the date of dialysis initiation and were followed until the earliest
of death, loss to follow-up, or the end of the observation period (December 31,
1998). Adjustment covariates for each of the death-on-dialysis, transplant, and
censoring hazard models, included age, sex, race, province, diagnosis, calendar
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Table 3 Simulation summary of estimates of survival functions for treated (S1) and un-
treated (S0) patients, and their difference (δ) at time t post treatment; Est: average of
estimates of quantity of interest across 1000 simulations; Bias: average bias across simula-
tions; ESD: empirical standard deviation of estimates from 1000 simulations; ASE: average
of estimated standard errors across simulations; CP: coverage probability of nominal 95%
confidence interval; Medium: medium treatment effect; Negative: negative treatment effect.
Setting t Quantity Est Bias ESD ASE CP
Medium 0.5 S0(t) 0.778 0.002 0.025 0.025 94.5
1.0 0.617 0.004 0.035 0.035 93.6
1.5 0.495 0.002 0.041 0.042 94.7
0.5 S1(t) 0.841 0.001 0.019 0.019 95.4
1.0 0.709 0.001 0.024 0.024 95.1
1.5 0.599 0.001 0.027 0.027 95.6
0.5 δ(t) 0.063 -0.001 0.031 0.031 94.5
1.0 0.092 -0.003 0.042 0.042 95.2
1.5 0.104 -0.001 0.049 0.049 95.1
Negative 0.5 S0(t) 0.777 0.001 0.026 0.025 94.4
1.0 0.614 0.001 0.034 0.035 95.2
1.5 0.495 0.002 0.042 0.041 95.2
0.5 S1(t) 0.599 0.002 0.026 0.025 93.4
1.0 0.364 0.001 0.026 0.026 95.2
1.5 0.225 0.000 0.024 0.023 93.7
0.5 δ(t) -0.178 0.003 0.036 0.036 93.4
1.0 -0.250 -0.001 0.042 0.043 95.7
1.5 -0.270 -0.002 0.048 0.047 95.1
year of therapy initiation, initial dialytic modality, and number of comorbid
conditions.
We set τ and τ1 to 3 years and 5 years, respectively. A total of 3,135
patients received a deceased-donor kidney transplant within the first 3 years
of follow-up. We performed prognostic score matching, with ξT = ξD = 1.05.
Under this matching scheme, all 3,135 transplants were matched. There were
619 observed deaths on dialysis and 460 post-transplant deaths.
Figure 2 shows Ŝ1(t), the average survival curve from the time of transplant
among patients transplanted, and Ŝ0(t) intended to represent the survival
curve (again, following transplant) to which the transplanted patients would
have been subjected had kidney transplantation been unavailable. Examining
Ŝ1(t), 1-, 3- and 5-year survival is estimated at 0.95, 0.90 and 0.85, respectively.
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In contrast, in the absence of kidney transplantation, 1-, 3- and 5-year survival
is estimated to be 0.92, 0.74 and 0.60. The lack of proportionality between the
Λ̂1(t) and Λ̂0(t) is examined more closely in the right panel in Figure 2 when
we magnify Ŝ1(t) and Ŝ0(t) such that only the (0, 1] year interval is displayed.
The crossing of the survival functions is apparent from this plot.
The proposed treatment effect estimator, δ̂(t) = Ŝ1(t)− Ŝ0(t), is presented
in Figure 3. For the first 4 months, it is estimated that survival is actually
higher on dialysis, δ̂(t) < 0, due to the mortality risk associated with surgery
not faced by patients continuing dialysis. From t=5 months on, we estimate
δ̂(t) > 0, the contrast being significant from t=9 months on.
5 Discussion
In this report, we developed matching methods to estimate pertinent survival
functions used in turn to estimate the average causal effect on the treated
of a time-dependent treatment. In particular, the proposed treatment effect
compares post-treatment survival with the survival experience to which the
treated patients would have been subjected in the absence of treatment. The
ATT is particularly interesting for policy makers in evaluating the realized
impact of treatment implementation given the observed treatment assignment
patterns. The proposed methods do not require that pre- and post-treatment
death hazards are proportional. Analytical forms of the variances are proposed
and shown through simulations to work well in practical samples sizes. Our
methods are easy to implement in SAS or R and the code can be downloaded
at https://github.com/yunliyunli/Matching.
Several existing methods are related to those proposed. Generally, such
methods do not do one or more of the following: target the survival function;
estimate the ATT; use time-from-treatment as the time scale. Marginal struc-
tural models (Robins et al. 2000; Herna´n et al. 2000 and 2001; Petersen et al.
2007) usually target the causal hazard ratio, which generally cannot be used to
obtain survival functions due to the nature of the averaging. The accelerated
failure time model assumed in g-estimation (Robins et al. 1992; Lok et al. 2004;
Herna´n et al. 2005) measures ratios of mean survival times, as opposed differ-
ences between survival functions. Unlike the proposed methods, g-estimation
typically involves parameterizing the treatment effect. The treatment effect (a
time scale acceleration factor) is typically represented as a one-number sum-
mary, implicitly assuming that the treatment effect is equal for all patients.
The treatment effect can be parameterized more generally, but at increased
computational expense since a estimation requires a grid search. Parametric
g-computation (Robins 1986, 1987 and 1988; Taubman et al. 2009) could be
used to estimate the contrast in survival functions estimated by the proposed
methods. However, unlike the proposed methods, a post-treatment survival
model would be required. In contrasting our methods with the g-formula, the
latter would likely be more sensitive to model misspecification (Taubman et
al. 2009); i.e., since the models are used to actually simulate data, as opposed
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Fig. 2 Post-transplant average survival curves for dialysis and transplanted patients. Left:
Estimates and 95% confidence intervals for 5-year post-transplant survival curves; Right:
Estimates for 1-year post-transplant survival curves
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Fig. 3 Estimate and 95% confidence interval for difference between post-transplant average
survival curves for dialysis and transplanted patients
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to classify or weight subjects. Additionally, matching can handle high dimen-
sional covariates (Rosenbaum and Rubin 1983). Conversely, g-computation
could offer efficiency gains relative to the proposed methods, if the assumed
models were all correct. With respect to computational convenience, the g-
formula would require the bootstrap, which is cumbersome for large data sets;
e.g., the CORR database we analyzed in Section 4.
Since we consider time-constant covariates, the data structure of our inter-
est can be considered a special case of that dealt with in the methods listed
in the preceding paragraph. It would appear that our methods could readily
be extended to handle time-dependent covariates. It seems that our methods
would carry through as detailed in Section 2, if the assumed models for each
of censoring, treatment and pre-treatment death were modified to incorporate
time-dependent covariates. Our interest was not in this area since, like many
large registry-based data sets, time-dependent covariates were not present in
the motivating example.
Each of the three different matching methods we considered (propensity
score matching, prognostic score matching and double matching) yields unbi-
ased treatment effect estimators in our simulations. However, prognostic score
matching appears to provide the most efficient estimators, which reflects the
importance to precision of adjusting for imbalances in covariates associated
with mortality. On the other hand, we observed that adjusting for covariates
associated only with treatment can actually increase the variance. Such find-
ings are consistent with those of Chen and Tsiatis (2001).
Propensity score matching was first proposed by Rosenbaum and Rubin
(1983), with its existing applications having mostly being limited to settings
wherein treatment is assigned at baseline. When treatment assignment is dy-
namic, as in a longitudinal observational study, Li, Propert and Rosenbaum
(2001) proposed a balanced risk set matching design, while Lu (2005) pro-
posed a time-dependent propensity score. However, these methods do not deal
with time-to-event outcomes or matching with replacement. Prognostic score
matching has been discussed by Hansen (2008) when the treatment is assigned
at baseline and is similar to the predicted mean matching in missing data lit-
erature (Little and Vartivarian 2005; Hsu and Taylor 2011). Time-dependent
prognostic score matching has been used by Prentice and Breslow (1978) for
a case-control study. Other work on time-dependent matching includes that
by Abbring and Van Der Berg (2004), Fredriksson and Johansson (2008),
Schaubel, Wolfe and Port (2006), and Schaubel et al (2009).
We used within-caliper nearest-neighbor matching with replacement, which
allows every treated patient to be matched to the yet-untreated patient with
the closest score, even if that match has been used previously for other treated
patients at previous different times. Matching with replacement reportedly
selects closer matches, produces more efficient and less biased estimates and
is less sensitive to the order of the matches, compared to matching without
replacement (Dehejia and Wahba 2002). In this paper, we conduct one-to-one
matching. However, there may be efficiency advantages to selecting multiple
matches per treated patient.
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We develop analytic techniques for estimating the variance of the pro-
posed estimators. The variance estimators account for the correlations arising
from the matching-with-replacement process, although the randomness in the
matching and inverse weighting processes is ignored. In our simulations, the
variance estimates were very close to the true values and the coverage prob-
abilities were close to the nominal level. Such approximations are attractive
since popular resampling methods (e.g., the bootstrap) often fail to yield valid
variance estimators in the presence of nearest-neighbor matching (Abadie and
Imbens 2008). Although the randomness introduced by matching and weight-
ing is often ignored (e.g., Stuart 2010), it would be worthwhile to further
investigate the impact of these considerations. Ideally, standard errors which
accounted for all sources of variation would be preferred, provided that the
result is computationally convenient.
The matching methods proposed here relies on the assumptions such as no
unmeasured confounding, overlapping support between treated and untreated
groups, no measurement errors and no model misspecification (Rosenbaum
and Rubin 1983). We also assume stable unit treatment value assumption
and strong ignorability of the treatment assignment given the propensity (or
prognostic or double) scores (Rubin 1974 and 1976; Rosenbaum and Rubin
1983). Our quantity of interest is ATT which is redefined for the common
support and can be more meaningful in practice when there is a self-selection
among the treated patients. The finite sample positivity violations and the
selection of common support impact our methods in terms of how large the
caliper needs to be made to ensure subjects are not thrown out from failure to
find a match. While we choose a caliper for simplicity, other choices of caliper
are worthy of exploration.
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